Zimmer Biomet Holdings Inc  

(Public, NYSE:ZBH)   Watch this stock  
Find more results for NYSE:ZMH
+0.54 (0.46%)
Feb 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 115.64 - 117.07
52 week 95.44 - 133.21
Open 115.91
Vol / Avg. 990,259.00/1.31M
Mkt cap 23.53B
P/E 78.07
Div/yield 0.24/0.82
EPS 1.50
Shares 200.20M
Beta 1.20
Inst. own 87%
Jan 26, 2017
Q4 2016 Zimmer Biomet Holdings Inc Earnings Release (Estimated)
Jan 10, 2017
Zimmer Biomet Holdings Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 3.31% 3.93%
Operating margin 9.20% 10.77%
EBITD margin - 32.33%
Return on average assets 1.00% 1.12%
Return on average equity 2.76% 3.11%
Employees 17,500 -
CDP Score - 62 E


345 E Main St
WARSAW, IN 46580-2746
United States - Map
+1-574-2676131 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc., is engaged designing, manufacturing and marketing orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions helps treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consists of the United States and includes other North, Central and South American markets; EMEA, consists of Europe and includes the Middle East and African markets, and Asia Pacific, consists of Japan and includes other Asian and Pacific markets. Its four product category segments include Americas Spine, Bone Healing Craniomaxillofacial and Thoracic, and Dental.

Officers and directors

David C. Dvorak President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Daniel P. Florin Chief Financial Officer, Senior Vice President
Age: 52
Bio & Compensation  - Reuters
Robert D. Delp President, Americas
Bio & Compensation  - Reuters
Katarzyna Mazur-Hofsaess M.D. Ph.D. President, Europe, Middle East and Africa
Age: 52
Bio & Compensation  - Reuters
Sang Yi President, Asia Pacific
Age: 54
Bio & Compensation  - Reuters
Chad F. Phipps Senior Vice President, General Counsel, Secretary
Age: 44
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tony W. Collins Chief Accounting Officer, Vice President, Corporate Controller
Age: 47
Bio & Compensation  - Reuters
Adam Rudolph Johnson Group President, Spine, Dental, CMF and Thoracic
Age: 38
Bio & Compensation  - Reuters
David A. Nolan Jr. Group President of Biologics, Extremities, Sports Medicine, Surgical, Trauma, Foot and Ankle and Bone Healing
Age: 50
Bio & Compensation  - Reuters
Daniel E. Williamson Group President, Joint Reconstruction
Age: 50
Bio & Compensation  - Reuters